Business Johnson & Johnson Covid vaccine: Analysts are cautiously optimistic On Jan 11, 2021 analystsBiotech and Pharmaceuticalsbusiness newscautiouslyCovidHealth care industryJohnsonJohnson & Johnson Share FacebookTwitterReddItWhatsAppPinterestEmailLinkedinTumblrTelegramVKViber